X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with PLETHICO PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs PLETHICO PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS PLETHICO PHARMA DR. DATSONS LABS/
PLETHICO PHARMA
 
P/E (TTM) x -10.9 -1.1 - View Chart
P/BV x 0.2 0.0 968.7% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 DR. DATSONS LABS   PLETHICO PHARMA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
PLETHICO PHARMA
Mar-14
DR. DATSONS LABS/
PLETHICO PHARMA
5-Yr Chart
Click to enlarge
High Rs126395 31.8%   
Low Rs3131 98.7%   
Sales per share (Unadj.) Rs133.0604.4 22.0%  
Earnings per share (Unadj.) Rs0.232.5 0.5%  
Cash flow per share (Unadj.) Rs6.651.3 12.9%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs128.8473.6 27.2%  
Shares outstanding (eoy) m31.6634.08 92.9%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.60.4 166.9%   
Avg P/E ratio x516.16.6 7,866.3%  
P/CF ratio (eoy) x11.84.2 285.2%  
Price / Book Value ratio x0.60.5 135.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,4777,262 34.1%   
No. of employees `000NANA-   
Total wages/salary Rs m561,596 3.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m4,21120,598 20.4%  
Other income Rs m79386 20.4%   
Total revenues Rs m4,28920,984 20.4%   
Gross profit Rs m5692,818 20.2%  
Depreciation Rs m204642 31.8%   
Interest Rs m4301,593 27.0%   
Profit before tax Rs m13969 1.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6-138 -4.4%   
Profit after tax Rs m51,107 0.4%  
Gross profit margin %13.513.7 98.7%  
Effective tax rate %48.0-14.3 -336.2%   
Net profit margin %0.15.4 2.1%  
BALANCE SHEET DATA
Current assets Rs m6,85218,877 36.3%   
Current liabilities Rs m6,71111,896 56.4%   
Net working cap to sales %3.333.9 9.9%  
Current ratio x1.01.6 64.3%  
Inventory Days Days16136 447.6%  
Debtors Days Days318198 161.0%  
Net fixed assets Rs m3,6739,861 37.2%   
Share capital Rs m317341 92.9%   
"Free" reserves Rs m3,76112,331 30.5%   
Net worth Rs m4,07816,139 25.3%   
Long term debt Rs m1,6714,706 35.5%   
Total assets Rs m12,63333,146 38.1%  
Interest coverage x1.01.6 64.0%   
Debt to equity ratio x0.40.3 140.5%  
Sales to assets ratio x0.30.6 53.6%   
Return on assets %3.48.1 42.3%  
Return on equity %0.16.9 1.7%  
Return on capital %7.712.3 62.4%  
Exports to sales %22.921.4 107.1%   
Imports to sales %14.315.2 93.9%   
Exports (fob) Rs m9644,402 21.9%   
Imports (cif) Rs m6023,136 19.2%   
Fx inflow Rs m9644,402 21.9%   
Fx outflow Rs m6073,184 19.1%   
Net fx Rs m3571,219 29.3%   
CASH FLOW
From Operations Rs m1,3452,437 55.2%  
From Investments Rs m-2,256-6,265 36.0%  
From Financial Activity Rs m-1,2002,490 -48.2%  
Net Cashflow Rs m-2,111-1,337 157.8%  

Share Holding

Indian Promoters % 4.5 82.7 5.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 4.3 -  
FIIs % 1.4 5.5 24.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 7.5 1,254.7%  
Shareholders   20,807 10,665 195.1%  
Pledged promoter(s) holding % 0.0 85.7 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   PFIZER  ABBOTT INDIA  FRESENIUS KABI ONCO.  WYETH LTD  GSK PHARMA  

Compare DR. DATSONS LABS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Firm US Markets; Sun Pharma, Software Stocks & Other Top Cues to Sway the Markets Today(Pre-Open)

Indian share markets finished the previous trading session on a strong note amid firm Asian markets after comments from a Federal Reserve official eased worries about faster rate hikes in US.

Related Views on News

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

Khadim India Ltd. (IPO)

Oct 31, 2017

Should you subscribe to the IPO of Khadim India Ltd?

Mahindra Logistics Ltd. (IPO)

Oct 28, 2017

Should you subscribe to the IPO of Mahindra Logistics Ltd?

Godrej Agrovet Ltd. (IPO)

Oct 4, 2017

Should you subscribe to the IPO of Godrej Agrovet Limited?

Matrimony.com (IPO)

Sep 11, 2017

Should you subscribe to the IPO of Matrimony.com?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

A New Quest for the Stock Market's MOST Profitable Ideas...(Smart Contrarian)

Feb 23, 2018

If you want to receive the best ideas in the Indian stick markets...you need to heed this important announcement.

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS